Category: Antibody Technologies
Global Antibody Technologies
-
Bioprocess Analyzers Market (Product: Instruments and Consumables & Accessories: and Application: Antibiotics, Recombinant Proteins, Biosimilars, and Monoclonal Antibodies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Report TMR’s report on the global bioprocess analyzers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period ... Read More
-
Global Secondary Antibodies Market Growth 2024-2030
... Antibodies is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Secondary Antibodies market. Secondary Antibodies ... Read More
-
Innovation Waves in Immuno-oncology Therapy Development
... prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, including monoclonals, antibody-drug conjugates (ADCs), bispecific antibodies, ... Read More
-
Recombinant Proteins Market Assessment, By Product [Cytokines and Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones, Others], By Host Cell [Mammalian Systems, Insect Cells, Yeast and Fungi, Bacterial Cells, Others], By Application [Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Diagnostics, Other Applications], By End-user [Pharmaceutical and Biotechnology Companies, Academics and Research Institutions, Clinical Research Organization, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Application [Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Diagnostics, Other Applications], By End-user [Pharmaceutical and Biotechnology Companies, Academics and Research Institutions, Clinical Research Organization, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F Global ... Read More
-
Global Trastuzumab Market Growth 2024-2030
... to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trastuzumab market. Trastuzumab are expected to show stable ... Read More
-
Biologics Market Assessment, By Product [Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, Gene-Based Biologics, Therapeutic Enzymes, Others] By Application [Infectious Diseases, Cancer, Autoimmune Diseases, Cardiovascular, Hematological Disorders, Others] By Drug Classification [Branded Drugs, Generic Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F
... Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F Global biologics market size was valued at USD 401.34 billion in ... Read More
-
Arthritis Monoclonal Antibodies Global Market Report 2024
... Research InstitutesCovering: Johnson & Johnson; Hoffmann-La Roche Ltd.; Novartis AG; Pfizer Inc.; AbbVie Inc. Arthritis Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Global Methylation Antibodies Market Growth 2024-2030
... % from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “Methylation Antibodies Industry Forecast” looks at past sales and reviews total world Methylation Antibodies sales in 2023, providing a comprehensive analysis ... Read More
-
Breast Cancer Monoclonal Antibodies Global Market Report 2024
... Covering: Amgen Inc.; Mylan N.V.; Merck & Co. Inc.; Novartis AG; GlaxoSmithKline plc. Breast Cancer Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Biosimilar Monoclonal Antibodies Global Market Report 2024
... Inc.; Coherus BioSciences; Biocon Limited Biosimilar Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report ... Read More
-
Monoclonal Antibodies (MAs) Global Market Report 2024
... Research Institute Covering: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Amgen Inc.; Novartis International AG Monoclonal Antibodies (MAs) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Protein Labeling Global Market Report 2024
... Spectrometry; Protein Micro AssayCovering: Thermo Fisher Scientific Inc.; Merck KGaA; PerkinElmer Inc.; General Electric Company; F. Hoffmann-La Roche AG Protein Labeling Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Conjugated Monoclonal Antibodies Global Market Report 2024
... F. Hoffmann-La Roche AG; Bristol -Myers Squibb; Merck & Co. Inc.; Immunomedics Inc. Conjugated Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
Global Antibody Drug Conjugates Market - Forecasts from 2024 to 2029
... of US$38.885 billion by 2029, increasing from US$7.017 billion in 2022. Antibody Drug Conjugates, or ADCs for short, are biological drugs designed as a targeted therapy for treating cancer. Antibody-drug conjugates provide sensitive differentiation between ... Read More
-
Postmenopausal Osteoporosis Treatment Market Forecasts to 2030 – Global Analysis By Treatment Type (Bisphosphonates, Hormone Replacement Therapy (HRT), Selective Estrogen Receptor Modulators (SERMs), Monoclonal Antibodies, Calcium and Vitamin D Supplements, Anabolic Agents and Other Treatment Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography
... Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography According to Stratistics MRC, the Global Postmenopausal Osteoporosis Treatment ... Read More
-
Protein Engineering Market - By Product (Instrument, Reagent, Software & Services), Technology (Irrational, Rational), Protein (Insulin, Monoclonal Antibody, Vaccine, Growth Factor, Coagulation Factor, Interferon), End-use - Global Forecast, 2024 - 2032
... size is projected to accrue over 15.9% CAGR between 2024 and 2032, propelled by substantial investments from startups. The influx of innovative ventures is injecting dynamism into the industry, driving advancements in protein-based therapeutics, industrial ... Read More
-
Polyclonal Antibodies Global Market Report 2024
... Companies; Diagnostic Centers; HospitalsCovering: Abcam plc; GenScript Biotech Corporation; Merck KGaA; Thermo Fisher Scientific Inc.; Becton Dickinson and Company Polyclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028
... to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period. The growth of this market can be attributed to the increasing ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Global Monoclonal Antibody Therapy Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Monoclonal Antibody Therapy industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Monoclonal Antibody Therapy. The report also introduces players ... Read More
-
Pleurodynia Treatment Market by Diagnosis (Blood Test, Culture Test, X-ray), Treatment (Analgesics, Immunoglobulin), Mode Of Administration, End-User - Global Forecast 2024-2030
... expected to reach USD 145.40 million in 2024, at a CAGR 5.66% to reach USD 203.54 million by 2030. Global Pleurodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Global Forecast 2024-2030
... and expected to reach USD 78.60 billion in 2024, at a CAGR 12.89% to reach USD 163.28 billion by 2030. Global Cancer Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2024-2030
... reach USD 468.61 million in 2024, at a CAGR 4.52% to reach USD 612.00 million by 2030. Global Radioimmunoassays Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Radioimmunoassays Market. It ... Read More
Research Assistance
